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Abstract: 
Manganese (Mn) is an essential metal required for normal homeostasis. Humans chronically 
exposed to high Mn levels, however, may exhibit psychomotor signs secondary to increased 
brain Mn. As Mn and iron (Fe) share several cellular membrane transporters, decreased Fe levels 
resulting from Fe deficiency or anemia lead to increased brain Mn deposition. Conversely, 
decreased Mn levels are associated with abnormal brain Fe accumulation. To reduce potential 
Mn toxicity resulting from brain Mn accumulation, we proposed that increased dietary Fe would 
attenuate brain Mn deposition. To test this hypothesis, three groups of Sprague-Dawley rats were 
injected weekly (14 weeks) with Mn (3 mg/kg) and fed normal Fe (TX), Fe-supplemented (FeS), 
or Fe-deficient (FeD) chow. Control (CN) rats received normal dietary Fe and saline injections. 
Using magnetic resonance imaging, rats were imaged biweekly for 14 weeks to qualitatively 
monitor brain Mn and Fe accumulation. Both FeS and FeD had greater brain Mn deposition than 
TX rats. By week 3, R1 values, which correlate with Mn deposition, were statistically 
significantly increased (p < 0.05) in brain stem, cerebellum, cortex, midbrain, and striatum 
compared with CN or TX animals. By week 14, R1 values for all brain regions in FeS and FeD 
animals were statistically significantly increased (p < 0.05). By the end of the study, similar 
results were obtained for R2 values, a marker of Fe accumulation. These data suggest that Fe 
supplementation does not effectively protect and may even exacerbate brain Mn accumulation in 
mammals subchronically exposed to Mn. 
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Article: 
Although manganese (Mn) is an essential metal required for proper growth and homeostasis 
(Wedler, 1994), exposure to high levels of this micronutrient can lead to a neurological disorder, 
termed manganism, which shares multiple clinical similarities with Parkinson's disease (Calne et 
al., 1994; Pal et al., 1999). Early symptoms of manganism include psychiatric changes, such as 
increased anxiety and impairments in learning and memory. As the disease progresses, the basal 
ganglia become affected, resulting in motor involvement manifesting as tremors and rigidity. 
Once motor functions deteriorate, the disease is often irreversible, even if the patient is removed 
from the source of Mn exposure (Pal et al., 1999). Typically, humans occupationally exposed to 
Mn from welding (Josephs et al., 2005; Racette et al., 2005), Mn mining (Myers et al., 2003a), or 
smelting (Myers et al., 2003b) are at the greatest risk for the disease when Mn exposure 
approaches 5 mg Mn/m3 (National Institute for Occupational Safety and Health, 2005). 
Additionally, neonates and older populations administered total parenteral nutrition (Fitzgerald et 
al., 1999) or patients suffering from liver disease (Klos et al., 2005; Park et al., 2003) may 
accumulate abnormally high concentrations of brain Mn. 
 
Rodents, nonhuman primates, and humans suffering from iron (Fe) deficiency or anemia have 
greater propensity to accumulate Mn in several tissues, including the brain (Erikson et al., 2004; 
Park et al., 2007b). This is particularly alarming as approximately 2 billion people worldwide 
suffer from Fe deficiency or Fe-deficient (FeD) anemia (de Benoist et al., 2008). Additionally, 
numerous countries are either considering the addition of methylcyclopentadienyl Mn tricarbonyl 
to gasoline as an antiknock agent replacement for lead or they have already implemented this 
practice (Boudia et al., 2006; Rollin et al., 2005). Such usage could lead to a scenario whereby 
human populations are chronically exposed from birth to high levels of atmospheric Mn (Boudia 
et al., 2006; Rollin et al., 2005). 
 
Although numerous studies have examined brain Mn accumulation at various and discrete time 
points in numerous tissues (Erikson et al., 2007; Park et al., 2007a), few have simultaneously 
followed brain Mn and/or Fe deposition during a subchronic exposure paradigm. Furthermore, 
only a small number of studies have examined the effects of dietary Fe on brain Mn deposition 
(Chua and Morgan, 1997). Accordingly, the present study was designed to test the following 
hypothesis: Rodents subchronically exposed to Mn and fed an FeD diet would have greater brain 
Mn deposition compared with animals fed a diet with normal Fe concentrations. Additionally, an 
Fe-supplemented (FeS) diet would result in brain Mn levels more consistent with those of 
animals receiving saline rather than Mn injections. The kinetic profile of brain Mn accumulation 
over the course of the 14-week experimental period was conducted by means of magnetic 
resonance imaging (MRI). A final objective of this study was to determine whether changes in 
Fe status result in differential accumulation of brain Mn. 
 
MATERIALS AND METHODS 
Animals. 
All animal protocols were approved by the Vanderbilt University Medical Center Institutional 
Animal Care and Use Committee. Male Sprague-Dawley rats (240–250 g) were ordered from 
Harlan (Indianapolis, IN). Rats had free access to food and water during the 14-week 
experimental protocol. Control (CN; n = 5) and Mn-treated (TX; n = 6) rats received normal 
rodent chow containing 30 mg Fe/kg and 10 mg Mn/kg chow. Similar to other studies from our 
laboratory (Erikson et al. 1997, 2002, 2004; Fitsanakis et al. 2008), two additional groups 
received diets with modified Fe levels: the FeD (FeD; n = 6) group was fed a specially 
formulated diet with reduced levels of Fe (3 mg Fe/kg chow) and the FeS (n = 4) group received 
a diet with 300 mg Fe/kg chow. Both Fe-modified diets were formulated and assayed for Fe 
content by BioServ (Frenchtown, NJ) and were designed to provide 10× less (FeD) or 10× more 
(FeS) Fe than the normal daily allowances for rodents (National Research Council, 1995), 
whereas Mn levels in the chow remained unchanged. In addition to dietary modifications, 
animals from the three treatment groups (TX, FeD, and FeS) received weekly intravenous (iv) 
tail injections of a sterile, isotonic Mn solution (3 mg Mn/kg) of MnCl2 for a total of 14 weeks. 
CN rats received injections of similar volumes of sterile, isotonic saline. Although humans are 
generally exposed to Mn via inhalation, this results in rapid entry into the blood stream. As such, 
iv exposure was chosen for this subchronic study. Rats were weighed weekly as a gross measure 
of general health. 
 
Magnetic resonance imaging. 
Upon arrival at Vanderbilt, rats were allowed to adjust to their new environment for 4–6 days 
prior to any handling or testing. Following this acclimation period, all animals were imaged as a 
baseline prior to initiation of their respective treatments. Rats were also imaged every 2 weeks, 
starting at week 1 of the treatment (weeks 1, 3, 5, 7, 9, 11, and 13). Finally, they were imaged at 
week 14, the last week of the study. In order to maintain consistency during the study, animals 
were always imaged 24 h after the respective week's injection of MnCl2 or saline. 
 
During the imaging, animals were anesthetized with 2% isoflurane and placed in a stereotaxic 
support cradle with their heads secured by surgical adhesive tape. The cradle was put in the 
volume coil to ensure that the rat's head was located in the coil′s center. Isoflurane was then 
lowered to 1.5–1.75%, and this ventilation mixture was maintained for the duration of the 
scanning protocol, usually 1.5 h, to ensure an appropriate level of unconsciousness sufficient to 
prevent duress in the animals. During the scan, body temperature was maintained at 37°C with 
warm air controlled by a rectal temperature probe (SA Instruments). Respiration was monitored 
throughout and maintained at 50–70 breaths per minute. 
 
All experiments were acquired using a 4.7-T, 31-cm bore Varian INOVA magnet with actively 
shielded gradients (40 G/cm, rise time full amplitude of 130 μs) and 63 mm transmit/receive 
quadrature imaging volume coil of Litz design with high B1 homogeneity over the rat brain. Rat 
brains were scanned from both axial (field of view [FOV] = 40 × 40 mm, 30 slices) and coronal 
directions (FOV = 40 × 50 mm, 20 slices) with 0.75 mm slice thickness. T1 was measured by 
progressive saturation (multiple flip angles) using a standard Varian 2-D multislice Fast Low 
Angle Shot sequence with radio frequency (RF) and gradient spoiling: repetition time/echo time 
= 489/6.59 ms; flip angles = 10°, 30°, 55°, or 70°; 2 acquisitions; and image matrix = 256 × 256. 
T2 was measured using a multislice multi-cecho fast spin echo sequence with parameters as 
follows: TR = 5100 ms; echo train length = 8; k-space center = 4; echo spacing = 5, 6.7, 10, 13, 
and 15 ms (effective TE = 20, 26.8, 40, 52, and 60 ms); 2 acquisitions; and image matrix = 128 × 
128. 
 
Brain dissection. 
At the conclusion of the study (week 14), rats were anesthetized with ketamine (80 mg/kg) and 
xylazine (12 mg/kg). When animals no longer responded to deep toe pinch, they were rapidly 
decapitated. Brains were removed and dissected into the following regions: cerebellum, brain 
stem (medulla and pons), midbrain, hippocampus, striatum, and cortex. The regions, which 
corresponded to those selected for imaging analysis, were quick frozen in dry ice and stored at 
−80°C until metal analysis by atomic absorption spectroscopy (AAS). 
 
Brain metal analysis by AAS. 
Tissue Mn and Fe concentrations were measured with graphite furnace AAS (Varian AA240, 
Varian, Inc.). Brain regions were digested in ultrapure nitric acid (1:10 wt/vol dilution) for 48–72 
h in a sand bath (60°C). One hundred microliters of digested tissue was brought to 1 ml total 
volume with 2% nitric acid and analyzed for Mn and Fe. Bovine liver (10 μg Mn/l) was digested 
in ultrapure nitric acid and used as an internal standard for analysis. 
 
Image analysis. 
T1 and T2 maps were calculated by fitting the series of T1- and T2-dependent images to the 
appropriate theoretical expressions using two-parameter least squares fits. The parametric maps 
were then co-registered to a high-resolution rat template and resliced using statistical parametric 
mapping (http://www.fil.ion.ucl.ac.uk/spm). Based on the rat brain template, multislice regions 
of interest (ROIs) were chosen for seven brain regions: cerebellum, brain stem, midbrain, 
striatum, hippocampus, cortex, and olfactory bulbs. Averaged values for the longitudinal 
relaxation rates, R1 (1/T1), and transverse relaxation rates, R2 (1/T2), within each of the ROIs 
were calculated for each rat and used in further statistical analyses. 
 
Statistical analyses. 
One-way ANOVA, with Bonferonni′s posttest, was used to compare brain metal data or total 
body mass gain for all four groups. All analyses were completed using GraphPad Prism version 
4.03 for Windows (GraphPad Software, San Diego, CA; http://www.graphpad.com). Either 
Tukey's honestly significant difference technique or Dunnet's post hoc analyses were used for 
multiple comparisons of the magnetic resonance (MR) data by treatment groups or weeks. All 
data were accepted as statistically significant if p < 0.05. 
 
RESULTS 
Changes in Body Mass 
 
Rats were dosed as outlined in “Materials and Methods” section. The Mn dose was chosen to 
approximate blood Mn levels observed in populations demonstrating Mn toxicity (Hauser et al., 
1996; Kim et al., 2005) without causing acute and overt toxicity in the rats. Beginning at week 3 
and continuing throughout the duration of the study, animals receiving the diet with normal Fe 
levels along with Mn injections (TX), those animals with an FeS diet receiving Mn injections 
(FeS), and those on an FeD diet that received Mn injections (FeD) all gained significantly less 
body mass compared with CN animals (p < 0.001; Fig. 1). Rats that received altered Fe levels 
(FeD and FeS) also gained significantly more than TX animals (p < 0.001; Fig. 1). Furthermore, 
although animals did not undergo a battery of behavioral tests, they were routinely handled 
during weighing and MR scans. In conjunction with these interactions, animals were carefully 
observed for increased tendency to bite handlers or alterations in walking pattern. None of the 
animals from any treatment groups (TX, FeS, or FeD) demonstrated overt changes in behavior 
(increased aggressiveness, abnormal posturing, and gait disturbances) sometimes associated with 
end-stage Mn toxicity. 
 
FIG. 1. 
Total body mass gain—Rats in each group were weighed weekly as a general assessment of 
overall health. Only the group receiving normal dietary levels of Fe and injected with Mn (TX) 
gained statistically significantly less body mass compared with CN rats (***p < 0.001) or TX 
rats (^^^p < 0.001). Data are normalized to average body mass at week 0 and presented as mean 
body mass gained ± SEM. 
Regional Changes in Longitudinal (R1) and Transverse (R2) Relaxation Rates 
 
We previously showed that both R1 and R2 depend in a complex way on tissue Mn and Fe levels 
and on the numbers of available binding sites for which Mn and Fe compete (Zhang et al., 2009). 
Nonetheless, these studies demonstrated that, under most conditions, regional increases in R1 
generally correlated with brain Mn deposition. It must be noted, however, that a quantitative 
determination of changes in tissue Mn from changes in R1 and/or R2 is complicated by the 
influence of concomitant changes in tissue Fe, as well as regional variations in the molar 
relaxivities of both species and in the concentration of available binding sites. We therefore 
monitored changes in R1 as a qualitative measure of brain changes in Mn deposition, inferring 
only that significant changes in R1 in a given region reflected significant changes in local Mn 
concentration. Following the first Mn injection at week 1, there were statistically significant 
increases (p < 0.05) in R1 values in all brain regions (Figs. 2A–F), except the striatum (Fig. 2G), 
in rats from all treated groups (TX, FeS, and FeD) compared with CN. By week 3, R1 values 
from all brain regions, except hippocampus (Fig. 2D) and olfactory bulb (Fig. 2F), in the FeS and 
FeD groups were statistically significantly higher (p < 0.05) compared with the TX group. The 
significantly increased R1 values persisted throughout the 14-week study period for all groups 
compared with the initial scan at week 0. Notably, the longitudinal relaxation rates from the 
discrete brain regions monitored in treated animals generally increased from the initial measured 
values at week 0. This is in contrast to R1 values for CN animals, which remained unchanged 
during the course of the study. 
Figure 2 has been omitted from this formatted document. 
Whereas it is well known that high tissue Fe concentrations lead to increased R2 and associated 
hypointensity on T2 and -weighted MRIs (McNeill et al., 2008), increases in tissue Mn can also 
significantly increase R2, and these effects may dominate (Zhang et al., 2009). By week 7, R2 
values for the brain stem, cerebellum, cortex, and hippocampus of animals in the FeS and FeD 
groups were statistically significantly increased (p < 0.05) compared with CN (Figs. 3A–D); no 
increases were observed in TX animals. In the midbrain and striatum, statistically significant 
increases in R2 values were apparent by week 5 (Figs. 3E and 3G), whereas increases in the 
olfactory bulbs of FeS and FeD animals were statistically significantly increased (p < 0.01) at 
week 3 (Fig. 3F) compared with CN. These increases in R2 values typically persisted throughout 
the 14-week study period. Compared with week 0, the mean differences in transverse relaxation 
rates for each brain region and each group did not reach the level of statistical significance until 
week 13. 
Figure 3 has been omitted from this formatted document.  
Regional Brain Metal Levels 
 
At the conclusion of the study, regional brain Mn (Fig. 4) and Fe (Fig. 5) levels were measured 
by AAS. Mn accumulation in the brain stem, striatum, and cortex from FeS and FeD animals 
was statistically significantly higher than both CN and TX animals (p < 0.05; Fig. 4). This was 
not the case for the hippocampus, however, where Mn accumulation was significantly lower 
compared with TX (p < 0.001; Fig. 4). Additionally, compared with CN and TX animals, rats in 
both the FeS and FeD groups had statistically significantly lower Fe accumulation in the 
cerebellum and cortex (p < 0.05; Fig. 5). 
FIG. 4. 
Brain Mn content—AAS was used to determine the amount of Mn in discrete brain regions at the 
conclusion of the study. The following symbols are used to denote statistical significance: *p < 
0.05, **p < 0.01, and ***p < 0.001 compared with CN; ^p < 0.05, ^^p < 0.01, and ^^^p < 0.001 
compared with TX. 
 
FIG. 5. 
Brain Fe content—AAS was used to determine the amount of Fe in discrete brain regions at the 
conclusion of the study. The regions listed correspond to those analyzed by MR throughout the 
time course of the study. The following symbols are used to denote statistical significance: *p < 
0.05, **p < 0.01, and ***p < 0.001 compared with CN; ^p < 0.05, ^^p < 0.01, and ^^^p < 0.001 
compared with TX. 
 
 
DISCUSSION 
Although rats have dietary metal requirements that exceed those of humans (National Research 
Council, 1995), rats have been used extensively as a model organism for both Fe and Mn 
regulation in nutritional and toxicological studies (Anderson et al., 2007; Carpenter, 2001; Chua 
and Morgan, 1996, 1997; Davis et al., 1990). Additionally, it is well established in both rats and 
humans that Mn and Fe share common transport proteins (Forbes and Gros, 2003; Wang et al., 
2006) and that Mn homeostasis is affected by Fe levels (Chua and Morgan, 1996; Garcia et al., 
2006). Similarly, when Mn levels are disturbed, Fe homeostasis is also disrupted (Chen et al., 
2006; Garcia et al., 2006). In light of this inverse relationship, our original hypothesis was as 
follows: Because Fe deficiency, even in the absence of Mn exposure (Erikson et al., 2002, 2004), 
leads to increased brain Mn deposition, dietary Fe supplementation will decrease brain Mn 
accumulation. Interestingly, a literature review indicated a gap in our knowledge related to how 
Fe supplementation might affect the regulation of other trace metals in the brain. 
 
To test this hypothesis, we used noninvasive MRI over the course of a 14-week, subchronic 
study to determine regional R1 and R2 values for rats in four distinct groups (CN, TX, FeS, and 
FeD). These relaxation rates have been used in clinical and research settings to follow brain Mn 
(R1) (Kim, 2004; Zhang et al., 2009) and brain Fe (R2) deposition (McNeill et al., 2008; Zhang 
et al., 2009). The quantitative interpretation, however, of R1 and R2 changes in terms of changes 
in regional Mn and Fe is complex and beyond the scope of this study. Nonetheless, a unique 
strength of MRI R1 and R2 mapping for assessing qualitative changes in heavy metal deposition 
lies in the fact that each animal can be used as its own CN, thus requiring fewer total animals and 
reducing the effects of intersubject variance in longitudinal studies. 
 
The present study offers novel information on the temporal accumulation of brain Mn and its 
relationship to dietary Fe levels. Indication of statistically significant increases in Mn 
accumulation (vs. CN) began at week 1 in all brains regions, except the striatum (Fig. 2G), as 
suggested by increased longitudinal relaxation rates (R1; Figs. 2A–F). Interestingly, motor signs 
in latter stages of manganism rely on the involvement of the basal ganglia, including the striatum 
(Pal et al., 1999). Furthermore, increased Mn deposition, as suggested by R1 values, persisted 
throughout the study (week 14). Because the tissue Fe concentrations measured in brain regions 
collected from all three Mn treatment groups immediately following the last MRI measurements 
were the same as (hippocampus and striatum), or lower than (cerebellum, brain stem, midbrain, 
and cortex), but never higher than, in CN (Fig. 5), we interpreted the persistent increases in 
regional R1 for all three treatment groups as a reflection of regional increases in regional Mn 
levels. Consistent with this interpretation, Mn levels were increased or unchanged in all but the 
hippocampus (Fig. 4). The R1 changes were most pronounced in animals fed Fe-modified diets, 
either FeS or FeD. Indeed, TX animals (normal dietary Fe) typically did not demonstrate 
statistically significant increases in R1 values until either week 3 (brain stem; Fig. 2A) or week 5 
(cortex; Fig. 2C). 
 
Fe deficiency, both in humans and rodents, leads to an increase in brain Mn deposition (Erikson 
et al., 2004; Park et al., 2007b). Thus, it was not unexpected that brain Mn levels were increased 
in FeD rats (Fig. 2). Others have reported that Fe deficiency not only leads to the upregulation of 
divalent metal transporter-1 (DMT-1) and transferrin (Tf; Siddappa et al., 2003) but also 
stabilizes messenger RNA (mRNA) of various Fe regulating proteins (IRPs) with Fe regulating 
elements (IRE-1 or IRE-2). These nucleic acid (mRNA) and protein modifications are thought to 
regulate overall Fe homeostasis. Many of the IRPs, including DMT-1 and Tf, are also known to 
transport Mn (Au et al., 2008) and are upregulated in the brain following conditions of Fe 
deficiency (Erikson and Aschner, 2006; Garcia et al., 2007). Thus, when Fe concentrations are 
low, more Mn is likely transported into the brain because of decreased competition from blood or 
plasma Fe and increased expression of DMT-1 and Tf (Garcia et al., 2007). Our data extend 
these observations by demonstrating that, as early as week 3, combining an FeD diet with low 
doses of Mn is sufficient to significantly increase R1 values above those observed in animals on 
a normal diet (Fig. 2). This phenomenon persists throughout the exposure period, such that by 
week 14 the R1 values for all brain regions are significantly increased in FeD compared with TX 
animals (p < 0.01; Fig. 2). These increases were corroborated by means of AAS, showing 
elevated Mn levels in the cortex, striatum, brain stem, and cerebellum in the FeD and TX groups 
(Fig. 4). 
 
Although it has been suggested that changes in brain Fe levels can be tracked using T2-weighted 
or R2 and  mapping MR protocols (Kruit et al., 2008), our recent work (Zhang et al., 2009) has 
demonstrated that a complex multisite model is required to describe the quantitative dependence 
of regional tissue R1 and R2 on tissue Fe and Mn. Consistent with this, it is noteworthy that in 
both FeS and FeD groups, R2 values increased or remained unchanged in regions showing 
significant decreases in tissue Fe, suggesting that R2 lacks specificity for Fe changes, and indeed 
can be dominated by concomitant increases in tissue Mn. This study did, however, confirm that 
R1 changes provide a better qualitative method for tracking changing Mn levels noninvasively in 
vivo, albeit with questions remaining regarding the specificity of the measurement. As 
demonstrated in Figure 3, there was generally no statistically significant difference between R2 
values from CN and TX animals throughout the course of the study. The exceptions occur in the 
midbrain, olfactory bulbs, and striatum (Figs. 3E–G), where TX groups reach a statistically 
significant increase in R2 values (p < 0.05) by week 13, again consistent with an increase in 
tissue Mn. 
 
As mentioned previously, there is an interdependent relationship between Mn and Fe transport. 
As a result, it was anticipated that animals injected with Mn would show increased brain Mn and 
decreased Fe accumulation. Consistent with the postmortem findings that Mn levels were 
increased or unchanged, R1 and R2 values increased in FeD (and FeS) animals (Figs. 2 and 3), 
whereas tissue Fe levels measured at the end of the study were unchanged or decreased. Whereas 
our data do not provide direct evidence for a mechanism of action, recent in vitro data suggest 
that decreased Fe leads to increases in functional ferroportin (Yin et al., 2009), which then 
promotes the extrusion of Fe from internal stores (De Domenico et al., 2007). 
 
It is more difficult to explain the brain Mn accumulation in animals receiving an Fe-fortified diet, 
although this has been reported previously by others (Chua and Morgan, 1996). Fe 
supplementation, however, results in the degradation of ferroportin. Thus, when dietary Fe levels 
are high, there is decreased cellular Fe efflux, ultimately resulting in decreased Fe availability for 
Tf/Tf receptor (TfR) transport (Rossi, 2005). As Tf/TfR is known to transport Mn (Li et al., 
2006; Takeda et al., 2000), decreased extracellular Fe (from ferroportin degradation) may result 
in increased Mn accumulation via Tf/TfR (Roth, 2006). Thus, as extracellular Fe concentrations 
decrease, it is possible that brain Mn transport increases. Although this hypothesis is certainly 
testable, it was beyond the scope of the work presented here. 
 
In summary, our data indicate that both subchronic Fe supplementation and deficiency coupled 
with a low dose of Mn lead increased brain Mn deposition. Whereas Fe deficiency, in the 
absence of Mn exposure, can result in increased brain Mn deposition, Fe supplementation does 
not ameliorate this accumulation. Future research should continue to focus on mechanisms 
related to Mn dysregulation in the presence of changes in dietary Fe. 
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